Legit.ng on MSN12h
Stock Market Rises Slightly by 0.04%, Continues Strong Start to New Week
The Nigerian stock market closed Tuesday with another gain, helping stock investors to make N26bn in hours as May & Baker ...
Before QAnon and the Deep State, There Was Iron Mountain
A new book by Phil Tinline recounts the history of a 1967 hoax and its ongoing influence as source code for antigovernment ...
Mural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock Plunges
Mural Oncology ends nemvaleukin development for ovarian cancer after ARTISTRY-7 trial misses survival goals. Phase 2 trials ...
What does it mean for alcohol stocks that Generation Z does not drink as much as their parents?
Analysis on the sluggish reports on alcohol sales have leaned on the theory that post-COVID normalization trends and economic ...
Should You Invest in the CoreWeave IPO? History Offers a Clear Answer.
After analyzing a couple of high-profile technology IPO stocks from recent years, my hope is that investors will come away ...
ChatGPT Can Now Edit Photos Better and Create Charts for Work
OpenAI is making it easier to edit images in ChatGPT and create visuals for work that include lengthy, legible text, ...
Is College Still Worth It Economically?
Fueled in part by the GI Bill, college became the engine of class mobility in the 20th century. Almost 40% of Americans have ...
OpenAI launches native image generation for 4o in ChatGPT and Sora
OpenAI launched native image generation for its 4o model in ChatGPT and Sora today. Native image generation is the ability of ...
OpenAI just unveiled enhanced image generator within ChatGPT-4o — here's what you can do now
OpenAI today announced the GPT-4o image generator, introducing advanced image generation capabilities integrated within the ChatGPT-4o language model. The company says that GPT-4o represents a ...
Erdene Announces Year-End Results and Provides Bayan Khundii Project Update
Peter Akerley, Erdene’s President and CEO stated, “The past year was a period of significant progress for Erdene with the ...
The Manila Times19h
Aprea Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea”, or the "Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...